IE45144B1 - Aminoalkyl esters of carbamimidothioic acid and compositions having immunosuppressant activity - Google Patents
Aminoalkyl esters of carbamimidothioic acid and compositions having immunosuppressant activityInfo
- Publication number
- IE45144B1 IE45144B1 IE947/77A IE94777A IE45144B1 IE 45144 B1 IE45144 B1 IE 45144B1 IE 947/77 A IE947/77 A IE 947/77A IE 94777 A IE94777 A IE 94777A IE 45144 B1 IE45144 B1 IE 45144B1
- Authority
- IE
- Ireland
- Prior art keywords
- isothiourea
- formula
- lower alkyl
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB19994/76A GB1592453A (en) | 1976-05-14 | 1976-05-14 | Aminoalkyl esters of carbarimidothioic acid and compositions having immunosuppressant activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE45144L IE45144L (en) | 1977-11-14 |
| IE45144B1 true IE45144B1 (en) | 1982-06-30 |
Family
ID=10138568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE947/77A IE45144B1 (en) | 1976-05-14 | 1977-05-10 | Aminoalkyl esters of carbamimidothioic acid and compositions having immunosuppressant activity |
Country Status (23)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0672244B2 (ja) * | 1984-12-12 | 1994-09-14 | 三菱マテリアル株式会社 | 貴金属造粒装置 |
| EP0702554A1 (en) * | 1993-06-07 | 1996-03-27 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| WO1996006076A1 (fr) * | 1994-08-18 | 1996-02-29 | Chugai Seiyaku Kabushiki Kaisha | Derives aminoacides exerçant une activite inhibitrice de la synthetase du monoxyde d'azote |
| US7645873B2 (en) * | 2003-03-20 | 2010-01-12 | The Scripps Research Institute | 6″-amino-6″-deoxygalactosylceramides |
| EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
| JP5809560B2 (ja) * | 2008-10-08 | 2015-11-11 | アビヴァックス | インフルエンザに対して使用するためのワクチン組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2648710A (en) * | 1950-09-22 | 1953-08-11 | Hoffmann La Roche | Bis-quaternary salts of 1:10-bis-(dialkylamino)-5:6-dithia-decane |
| US2813102A (en) * | 1956-04-10 | 1957-11-12 | American Home Prod | 2-(di-lower alkylaminoethylmercapto)-imidazolines and their acid addition salts and preparation thereof |
| US4152453A (en) * | 1975-12-01 | 1979-05-01 | Smith Kline & French Laboratories Limited | Pharmacologically active compounds and compositions and methods of use |
-
1976
- 1976-05-14 GB GB19994/76A patent/GB1592453A/en not_active Expired
-
1977
- 1977-05-02 ZA ZA00772612A patent/ZA772612B/xx unknown
- 1977-05-03 FI FI771400A patent/FI771400A7/fi not_active Application Discontinuation
- 1977-05-04 PT PT66509A patent/PT66509B/pt unknown
- 1977-05-04 IL IL52011A patent/IL52011A/xx unknown
- 1977-05-04 AT AT318277A patent/AT359521B/de not_active IP Right Cessation
- 1977-05-10 IE IE947/77A patent/IE45144B1/en unknown
- 1977-05-11 CH CH589877A patent/CH620203A5/fr not_active IP Right Cessation
- 1977-05-11 AU AU25079/77A patent/AU509573B2/en not_active Expired
- 1977-05-11 JP JP5483077A patent/JPS532420A/ja active Pending
- 1977-05-12 BE BE177510A patent/BE854553A/xx not_active IP Right Cessation
- 1977-05-13 LU LU77332A patent/LU77332A1/xx unknown
- 1977-05-13 HU HU77SI1576A patent/HU174978B/hu unknown
- 1977-05-13 AR AR267623A patent/AR218872A1/es active
- 1977-05-13 NL NL7705331A patent/NL7705331A/xx not_active Application Discontinuation
- 1977-05-13 ES ES458756A patent/ES458756A1/es not_active Expired
- 1977-05-13 FR FR7714766A patent/FR2351098A1/fr active Granted
- 1977-05-13 DK DK211277A patent/DK211277A/da not_active Application Discontinuation
- 1977-05-13 DE DE19772721830 patent/DE2721830A1/de not_active Withdrawn
- 1977-05-13 CA CA278,412A patent/CA1086758A/en not_active Expired
- 1977-05-13 NO NO771697A patent/NO771697L/no unknown
- 1977-05-16 SE SE7705658A patent/SE7705658L/xx unknown
-
1979
- 1979-10-09 US US06/082,836 patent/US4294854A/en not_active Expired - Lifetime
-
1980
- 1980-11-17 FR FR8024334A patent/FR2472935A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB1592453A (en) | 1981-07-08 |
| CA1086758A (en) | 1980-09-30 |
| NO771697L (no) | 1977-11-15 |
| DK211277A (da) | 1977-11-15 |
| FI771400A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-11-15 |
| AU2507977A (en) | 1978-11-16 |
| ZA772612B (en) | 1978-04-26 |
| PT66509B (en) | 1978-10-16 |
| LU77332A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-08-29 |
| AT359521B (de) | 1980-11-10 |
| AU509573B2 (en) | 1980-05-15 |
| SE7705658L (sv) | 1977-11-15 |
| NL7705331A (nl) | 1977-11-16 |
| PT66509A (en) | 1977-06-01 |
| FR2351098A1 (fr) | 1977-12-09 |
| AR218872A1 (es) | 1980-07-15 |
| HU174978B (hu) | 1980-04-28 |
| IL52011A (en) | 1982-05-31 |
| JPS532420A (en) | 1978-01-11 |
| IE45144L (en) | 1977-11-14 |
| BE854553A (fr) | 1977-11-14 |
| DE2721830A1 (de) | 1977-11-24 |
| FR2351098B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-06-18 |
| ES458756A1 (es) | 1978-03-01 |
| FR2472935A1 (fr) | 1981-07-10 |
| CH620203A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1980-11-14 |
| ATA318277A (de) | 1980-04-15 |
| US4294854A (en) | 1981-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3488423A (en) | Process for producing anti-inflammatory effects and compositions | |
| US3669968A (en) | Trialkoxy quinazolines | |
| SE457081B (sv) | 1,2-diaminocyklobutan-3,4-dioner, foerfarande foer framstaellning av dessa, mellanprodukt och en farmaceutisk komposition | |
| JPS5946221B2 (ja) | 複素環化合物の製法 | |
| HU179492B (en) | Process for producing 1,2,4-thiadiasole derivatives | |
| US4518712A (en) | Piperazine derivative and analgesic composition containing the same | |
| EP0221511B1 (en) | 2-aminosulfonyl-6-nitrobenzoic esters or amides, process for their preparation and pharmaceutical compositions containing them | |
| IE45144B1 (en) | Aminoalkyl esters of carbamimidothioic acid and compositions having immunosuppressant activity | |
| JPS5946220B2 (ja) | 複素環化合物の製法 | |
| US4066695A (en) | Thiourea derivatives | |
| US4104381A (en) | Pharmacologically active compounds | |
| US3574212A (en) | Quinazolinylureas | |
| EP0099122B1 (en) | Compositions comprising pepstatin and an histamine h2-receptor antagonist having an enhanced antiulcer activity | |
| US4205071A (en) | Pharmaceutical compositions having immunosuppressant activity and methods therefor | |
| US3531482A (en) | Pyrazolo(1,5-c)quinazolines | |
| US4546187A (en) | Piperidinoalkylthio pyridinium compounds | |
| US4652572A (en) | 2-(furanyl alkylamino or thienyl alkylamino or phenylalkylamino)-3-carboxy (or hydroxy)-pyridines | |
| US4399142A (en) | Pharmacologically active compounds | |
| US3654296A (en) | 2-chlorobenzothiazolecarboxamides | |
| US4153793A (en) | Imidazo alkylamino pyrimidones | |
| CS219885B2 (en) | Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide | |
| US4378365A (en) | Pharmaceutical compositions | |
| US4649138A (en) | Pharmaceutical compositions | |
| US4181730A (en) | Pharmacologically active compounds as inhibitors of H-2 histamine receptors | |
| NO772669L (no) | Fremgangsm}te for fremstilling av farmakologisk aktive forbindelser |